Corteva, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Corteva, Inc. Corteva, Inc. (CTVA) develops and supplies advanced seed and crop protection products to enhance agricultural productivity worldwide. The company operates through two primary segments, Seed and Crop Protection; the Seed segment offers high-performance hybrid and traited seeds for row crops such as corn and soybeans under brands including Pioneer and Brevant, alongside specialty seeds for fruits, vegetables, and other crops, supported by digital selection tools and biotechnology traits for insect resistance and herbicide tolerance; the Crop Protection segment provides herbicides including the Enlist system, insecticides, fungicides, nitrogen stabilizers, seed treatments, biologicals, and pasture management solutions to combat weeds, diseases, insects, and nematodes. Corteva serves farmers and the agricultural input industry across more than 140 countries, with a focus on integrated solutions that combine genetics, chemistry, and digital agriculture technologies; it maintains a global manufacturing footprint, robust research and development investment exceeding $1.3 billion annually in genomics, biotechnology, and new active ingredients, and key brands like Pioneer, founded in 1926. Headquartered in Indianapolis, Indiana since 2022 after relocating from Delaware, the company employs over 20,000 people and traces its origins to the 2019 spin-off from DowDuPont as a pure-play agriscience entity. Recent developments include the announcement in late September 2025 of plans to separate into two independent public companies along seed and crop protection lines, with current CEO Chuck Magro to lead the crop protection spin-co; additionally, Corteva entered a strategic collaboration and joint venture with gene-editing firm Pairwise in 2024, investing $25 million in equity to advance climate-resilient crops, and reaffirmed its Delaware presence in October 2025 by relocating corporate offices to downtown Wilmington while retaining over 200 jobs.
Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript
Corteva Inc (CTVA) (Q2 2026) Earnings Call Highlights: Strong First-Half Performance and Raised Guidance Amid Market Challenges
Corteva Q2 Earnings Call Highlights
Are You Looking for a Top Momentum Pick? Why Corteva, Inc. (CTVA) is a Great Choice
Corteva Q2 Earnings Beat Estimates, Sales Miss, '26 Outlook Raised
Corteva: Strong Fundamentals, Limited Upside
Corteva, Inc. (CTVA) Reports Q2 Earnings: What Key Metrics Have to Say
Corteva, Inc. (CTVA) Q2 Earnings Beat Estimates
Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation
Is CTVA Stock Worth Buying After a Powerful Rally and Earnings Beat?
Why Corteva's Seed and Crop Protection Engines Matter to Investors
How Corteva's Innovation Pipeline Could Shape Its Next Growth Cycle
Corteva, Inc. (CTVA) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Corteva, Inc. $CTVA Stock Holdings Lifted by Cetera Investment Advisers
Corteva, Inc. $CTVA Shares Sold by First Trust Advisors LP
Corteva, Inc. (CTVA) Upgraded to Buy: Here's What You Should Know
Corteva Set to Report Q2 Earnings: What Investors Should Expect
Corteva Declares Quarterly Dividend
ABN Amro Investment Solutions Sells 93,474 Shares of Corteva, Inc. $CTVA
Will Corteva, Inc. (CTVA) Beat Estimates Again in Its Next Earnings Report?